Janning, M., Müller, V., Vettorazzi, E., Cubas‐Cordova, M., Gensch, V., Ben‐Batalla, I., zu Eulenburg, C., Schem, C., Fasching, P. A., Schnappauf, B., Karn, T., Fehm, T., Just, M., Kühn, T., Holms, F., Overkamp, F., Krabisch, P., Rack, B., Denkert, C., Untch, M., Tesch, H., Rezai, M., Kittel, K., Pantel, K., Bokemeyer, C., Loibl, S., von Minckwitz, G., & Loges, S. (2019). evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial. International journal of cancer, 145(3), 857–868. http://access.bl.uk/ark:/81055/vdc_100086191599.0x00005a